Start with a free account for 3 free CME credits. Already a subscriber? Sign in.
Free Episode

The New Flu Review 2018-19

Solomon Behar, MD and Lisa Patel, MD

No me gusta!

The flash player was unable to start. If you have a flash blocker then try unblocking the flash content - it should be visible below.

Tag ID

Lisa and Sol review the latest recommendations issued by the American Academy of Pediatrics for the 2018-19 influenza vaccine and management of influenza illness.

Eliana A., PAC -

Everyone wants Oseltamivir the minute they get sick during flu season, but I have seen people present with behavioral/mood changes after 2 doses. Are there any studies looking at the incidence of side effects? Are there any studies on chemo prophylaxis for immuncompromised who are treated for 12 weeks.

Tabor D., PA-C -

I think in Japan there was a study that raised concern for Psych side effects in teens. Here are some studies.

Oseltamivir linked to abnormal behavior in children, label changes sought. Nov 26, 2007. Parker Waichman LLP. [Last accessed on 2014 May 28]. Available from: .

Toovey S, Rayner C, Prinssen E, Chu T, Donner B, Thakrar B, et al. Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: A comprehensive review. Drug Saf. 2008;31:1097–114. [PubMed]

Mike W., MD -

Thx Tabor!!

To join the conversation, you need to subscribe.

Sign up today for full access to all episodes and to join the conversation.

To download files, you need to subscribe.

Sign up today for full access to all episodes.